Analyst Activity – HC Wainwright Initiates Coverage On Marinus Pharmaceuticals (NASDAQ:MRNS) With a Buy

0

Analyst Ratings For Marinus Pharmaceuticals (NASDAQ:MRNS)

Today, HC Wainwright initiated coverage on Marinus Pharmaceuticals (NASDAQ:MRNS) with a Buy with a price target of $33.00.

Some recent analyst ratings include

  • 2/15/2018-HC Wainwright initiated coverage with a Buy rating.
  • 12/14/2017-Laidlaw initiated coverage with a Buy rating.
  • 9/12/2017-JMP Securities Reiterated Rating of Outperform.
  • 10/3/2016-Jefferies Group Reiterated Rating of Buy.
  • 6/28/2016-Stifel Nicolaus Reiterated Rating of Hold.
  • 6/14/2016-Goldman Sachs Group was Downgraded by analysts at Goldman Sachs Group from a “Buy ” rating to a ” Neutral” rating.
  • 6/14/2016-Oppenheimer was Downgraded by analysts at Oppenheimer from a “Outperform ” rating to a ” Market Perform” rating.

Recent Insider Trading Activity For Marinus Pharmaceuticals (NASDAQ:MRNS)
Marinus Pharmaceuticals (NASDAQ:MRNS) has insider ownership of 6.40% and institutional ownership of 52.58%.

  • On 1/29/2018 Edward F Smith, CFO, sold 3,000 with an average share price of $7.91 per share and the total transaction amounting to $23,730.00.
  • On 1/18/2018 Christopher Michael Cashman, CEO, sold 9,566 with an average share price of $6.28 per share and the total transaction amounting to $60,074.48.
  • On 12/19/2017 Bain Capital Life Sciences Inv, Major Shareholder, sold 1,272,547 with an average share price of $7.88 per share and the total transaction amounting to $10,027,670.36.
  • On 12/15/2017 Bain Capital Life Sciences Inv, Major Shareholder, sold 822,547 with an average share price of $8.10 per share and the total transaction amounting to $6,662,630.70.
  • On 10/20/2016 Anand Mehra, Major Shareholder, sold 750,683 with an average share price of $1.39 per share and the total transaction amounting to $1,043,449.37.
  • On 8/8/2016 Vii Lp Canaan, Major Shareholder, sold 149,154 with an average share price of $1.50 per share and the total transaction amounting to $223,731.00.
  • On 8/4/2016 Vii Lp Canaan, Major Shareholder, sold 145,583 with an average share price of $1.50 per share and the total transaction amounting to $218,374.50.

Recent Trading Activity for Marinus Pharmaceuticals (NASDAQ:MRNS)
Shares of Marinus Pharmaceuticals closed the previous trading session at 6.46 up +0.38 6.25% with 1086334 shares trading hands.

An ad to help with our costs